Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Achillion Pharmaceuticals, Inc.

Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been 
Filed Against Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) 
OKLAHOMA CITY, OK -- (Marketwired) -- 10/11/13 --  On October 8,
2013, a class action lawsuit was filed in the United States District
Court for the District of Connecticut against Achillion
Pharmaceuticals, Inc. (NASDAQ: ACHN). The complaint alleges
violations of federal securities laws, Sections 10(b) and 20(a) of
the Securities Exchange Act of 1934 and Rule 10b-5, including
allegations of issuing a series of material or false
misrepresentations to the market which had the effect of artificially
inflating the market price during the Class Period, which is April
21, 2012 through September 27, 2013. 
Plaintiff seeks to recover damages on behalf of all Achillion
Pharmaceuticals, inc. shareholders who purchased common stock during
the Class Period and are therefore a member of the Class as described
above. You may move the Court no later than Monday, December 9, 2013
to serve as a lead plaintiff for the entire Class. However, in order
to do so, you must meet certain legal requirements pursuant to the
Private Securities Litigation Reform Act of 1995. 
If you wish to discuss this action, obtain further information and
participate in this or any other securities litigation, or should you
have any questions or concerns regarding this notice or preservation
of your rights, please contact: 
K. Lynn Nunn
FEDERMAN & SHERWOOD 
10205 North Pennsylvania Avenue
Oklahoma City, OK 73120
Email to: kln@federmanlaw.com
Or, visit the firm's website at www.federmanlaw.com 
 
 
Press spacebar to pause and continue. Press esc to stop.